Palisade Capital Management’s Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 AMSGP Stock Holding History

Palisade Capital Management’s Portfolio AMSGP Stock Details AMSGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-35,016	Closed	-$4.43M	–	580
2016 Q3	$4.43M	Sell	35,016 -302	-0.9%	-$39.3K	0.16%	179
2016 Q2	$5.13M	Buy	35,318 +23	+0.1%	+$3.34K	0.19%	161
2016 Q1	$4.99M	Buy	35,295 +5,295	+18%	+$712K	0.16%	197
2015 Q4	$4.33M	Sell	30,000 -20,000	-40%	-$3.01M	0.14%	228
2015 Q3	$7.41M	Buy	50,000 +30,800	+160%	+$4.67M	0.22%	169
2015 Q2	$2.63M	Sell	19,200 -15,000	-44%	-$1.99M	0.07%	340
2015 Q1	$4.25M	Buy	+34,200	New	+$4.08M	0.11%	286

Palisade Capital Management's AMSGP Position: Q4 2016 in Review

Palisade Capital Management sold out of Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) in Q4 2016, closing a stake of 35,016 shares — an estimated $4.43M sold.

Palisade Capital Management first reported a position in AMSGP in Q1 2015 and held it in 7 quarters. The position peaked at $7.41M in Q3 2015. 0 funds tracked by Wall St. Rank hold AMSGP as of Q4 2016.

Palisade Capital Management reported no remaining Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position as of Q4 2016 after selling out during the quarter.
Palisade Capital Management sold 35,016 Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 shares in Q4 2016, an estimated $4.43M.
Palisade Capital Management first reported a position in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 in Q1 2015 and held it in 7 quarters.
Palisade Capital Management's Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position peaked at $7.41M in Q3 2015.
0 funds tracked by Wall St. Rank held Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 as of Q4 2016.

Based on Palisade Capital Management's 13F filing for Q4 2016, filed 31 Jan 2017.